Clinical Pearls in Blood Diseases
Successful treatment with rituximab in a patient with an acquired factor V inhibitor
Article first published online: 11 SEP 2007
Copyright © 2007 Wiley-Liss, Inc.
American Journal of Hematology
Volume 83, Issue 2, pages 163–164, February 2008
How to Cite
Lebrun, A., Leroy-Matheron, C., Arlet, J.-B., Bartolucci, P. and Michel, M. (2008), Successful treatment with rituximab in a patient with an acquired factor V inhibitor. Am. J. Hematol., 83: 163–164. doi: 10.1002/ajh.21056
- Issue published online: 2 JAN 2008
- Article first published online: 11 SEP 2007
- Manuscript Accepted: 18 JUL 2007
- Manuscript Revised: 17 JUL 2007
- Manuscript Received: 19 JUN 2007
Rituximab has already been successfully used to treat immune-mediated bleeding disorders such as acquired factor VIII inhibitor. We report here a case of severe acquired factor V (FV) inhibitor deficiency due to FV inhibitor which has been dramatically improved after rituximab. Am. J. Hematol., 2008. © 2007 Wiley-Liss, Inc.